Work

Hyperglycemia, hypertriglyceridemia, and hypercholesterolemia in a phase I trial of the combination of an mTOR inhibitor and IGF-1 receptor inhibitor.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2597

Authors: N. Busaidy, R. Kurzrock, P. LoRusso, A. D. Owens, H. X. Chen, L. Doyle, J. Zhang, K. Lawhorn, C. Chandhasin, A. Naing

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W177274944

Cites:

Cited by: 2

Related to: 10